Aardvark Therapeutics 

$5.38
13
-$0.35-6.11% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
5.36
Day Low
5.32
52W High
17.94
52W Low
3.35
Volume
5,409
Avg. Volume
-
Mkt Cap
117.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.99
-0.86
-0.73
-0.6
Expected EPS
-0.720909
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2023
2024
2025
0Revenue
-57.59MNet Income

Analyst Ratings

6.25Average Price Target
The highest estimate is 9.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
25%
Sell
25%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AARD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Show more...
CEO
Tien-Li Lee
Employees
28
Country
United States
ISIN
US0029421007

Listings

0 Comments

Share your thoughts

FAQ

What is Aardvark Therapeutics stock price today?
The current price of AARD is $5.38 USD — it has decreased by -6.11% in the past 24 hours. Watch Aardvark Therapeutics stock price performance more closely on the chart.
What is Aardvark Therapeutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Aardvark Therapeutics stocks are traded under the ticker AARD.
Is Aardvark Therapeutics stock price growing?
AARD stock has fallen by -7.08% compared to the previous week, the month change is a -26.3% fall, over the last year Aardvark Therapeutics has showed a -37.44% decrease.
What is Aardvark Therapeutics market cap?
Today Aardvark Therapeutics has the market capitalization of 117.74M
When is the next Aardvark Therapeutics earnings date?
Aardvark Therapeutics is going to release the next earnings report on November 12, 2026.
What were Aardvark Therapeutics earnings last quarter?
AARD earnings for the last quarter are -0.66 USD per share, whereas the estimation was -0.87 USD resulting in a +24.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aardvark Therapeutics revenue for the last year?
Aardvark Therapeutics revenue for the last year amounts to 0 USD.
What is Aardvark Therapeutics net income for the last year?
AARD net income for the last year is -57.59M USD.
How many employees does Aardvark Therapeutics have?
As of September 06, 2026, the company has 28 employees.
In which sector is Aardvark Therapeutics located?
Aardvark Therapeutics operates in the Health & Wellness sector.
When did Aardvark Therapeutics complete a stock split?
The last stock split for Aardvark Therapeutics was on July 21, 2008 with a ratio of 1:2.
Where is Aardvark Therapeutics headquartered?
Aardvark Therapeutics is headquartered in SAN DIEGO, United States.